About Elixir

Innovating Vascular Restoration™

Leading the way to next generation DES platforms

Elixir Medical Corporation was founded in 2005 to develop innovative products that combine state-of-the-art technology with advanced pharmaceuticals to provide innovative drug-device treatment solutions to patients worldwide.

The company's next-generation drug-eluting stent systems are designed to optimize localized drug delivery and provide a safe and effective treatment for cardiovascular disease.



Elixir Medical is a privately funded company. The lead investor is the Invus Group, a New York-based equity investment firm with over $4 billion under management.

To learn more about investment opportunities, contact info@elixirmedical.com.